Covid-19: SEC nod for Bharat Biotech to conduct Phase III booster dose study for its intranasal vaccine



from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pRjHgB
via IFTTT

0 comments:

Post a Comment